MICHEL SPAGNOL
- Shasun Pharmaceuticals in licensing pact with Swiss-based DebiopharmShasun Pharmaceuticals would be able to use the Debiopharm technology for manufacturing synthetic Huperzine-A and commercialise it.
- Shasun Chemicals enters non-exclusive deal with MerckShasun Chemicals has entered into a non-exclusive licensing agreement with Merck & Co Inc.
- Load More